Fundraising Fox
Wellest
Techstars '22San Francisco, US · 1 known investors
Find your way into Wellest
Sign up to see every warm intro you have to Wellest
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Wellest team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Wellest provides a digital platform for managing metabolic and endocrine disorders, using generative AI to help healthcare providers deliver treatment and allow patients to integrate care into their daily routines.
Also known as Wellest Inc.
Investors · 1
How we know: the Techstars portfolio · open dataset · Top 3000 Accelerator Startups (no YC) 2026-08 · Not right? Tell us
Company profile
researched Sep 2026Wellest Inc. develops an end-to-end digital platform for managing whole-body wellness that is used jointly by patients and their healthcare teams. The company positions the product around metabolic and endocrine disorders, applying generative AI with the stated aims of helping physicians deliver better clinical outcomes and letting patients fit treatment into their everyday routines.
The platform is delivered in part through an iOS application, which the company makes available to clinical trial patients via the App Store. As of the company's current site, Wellest is in private beta with a selected group of clinical providers and their patients, and collects email sign-ups for early access ahead of a public release.
Business model
Wellest offers a software platform used by both healthcare providers and their patients, distributed to patients through an iOS application; the platform is described as open and end-to-end, spanning the clinician and patient sides of metabolic and endocrine care.
Traction
Wellest is in private beta with select clinical providers and their patients and has an iOS app available to clinical trial patients. The Techstars job board lists the company at pre-seed stage with 1-10 employees.
Latest developments
Wellest remains in private beta with select clinical providers and their patients, with an iOS application available to clinical trial patients and a sign-up list for notifications about a public release.
▸Full profile — market position, technology, go-to-market, geography, history
Market position
An early-stage, pre-seed company in the digital metabolic and endocrine care category, and a Techstars portfolio company.
Technology
The product uses generative AI applied to the treatment of metabolic and endocrine disorders, packaged as an open end-to-end platform with a patient-facing iOS app.
Go-to-market
The company is running a private beta with selected clinical providers and their patients, and maintains an early-access email waitlist ahead of a public release. Distribution to clinical trial patients occurs through the iOS App Store.
Healthcare providers treating metabolic and endocrine disorders and their patients, including patients enrolled in clinical trials.
Geography
Listed in San Francisco, California, United States; the company describes itself as "Born in the Bay Area, Raised on the Third Coast."
History
The company is listed as founded in 2017 and is a Techstars portfolio company. It is currently operating a private beta of its platform with selected clinical providers and patients ahead of a general release.
Compiled by commissioned research from 8 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
▸Research sources · 8
primary sources listed
- Wellestwellest.com · web
8 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Wellest do?
- Wellest is a generative-AI platform for managing metabolic and endocrine disorders for patients and their care teams.
- Who are Wellest's investors?
- Wellest's investors include Techstars.
- Where is Wellest headquartered?
- Wellest is headquartered in San Francisco, US.